Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent Influenza Split-Virion Vaccine in Infants 6–35 Months
CTR20180096Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Feb 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent influenza vaccine in influenza, sponsored by Sinovac Biotech Ltd.. Started Feb 2018; status: completed.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20180096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180096.